Selected article for: "cumulative pulse and intravenous pulse"

Author: da Cunha, Gilmara Franco; de Souza, Fernando Henrique Carlos; Levy-Neto, Maurício; Shinjo, Samuel Katsuyuki
Title: Chloroquine diphosphate: a risk factor for herpes zoster in patients with dermatomyositis/polymyositis
  • Document date: 2013_5_23
  • ID: s9mqzqu4_27
    Snippet: Nagaoka et al. (15) analyzed five HZ cases among 22 DM/PM patients and noted that the infection affected more patients without disease activity; they found no correlation over time with corticosteroid use. Our results showed that HZ prevalence was independent of disease status and clinical and laboratory features, including cutaneous manifestations. Moreover, daily and/or cumulative dosages of corticosteroid and/or intravenous pulse methylprednis.....
    Document: Nagaoka et al. (15) analyzed five HZ cases among 22 DM/PM patients and noted that the infection affected more patients without disease activity; they found no correlation over time with corticosteroid use. Our results showed that HZ prevalence was independent of disease status and clinical and laboratory features, including cutaneous manifestations. Moreover, daily and/or cumulative dosages of corticosteroid and/or intravenous pulse methylprednisolone did not increase the risk for HZ development in our population. Likewise, using immunosuppressive therapy (methotrexate, azathioprine, mycophenolate mofetil, leflunomide and cyclophosphamide)-either alone or in combination-was not associated with HZ.

    Search related documents:
    Co phrase search for related documents
    • cutaneous manifestation and immunosuppressive therapy: 1
    • disease activity and HZ prevalence: 1
    • disease activity and immunosuppressive therapy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13